We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
This guidance is designed to provide information on the implementation of changes to advertising and promotion of medicines authorised in the UK from 1 January 2025.
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
Information to raise awareness with commissioners and providers of the community pharmacy offer for sexual health, reproductive health and HIV services.
Guidance on how to make reasonable adjustments to help support people with learning disabilities in using pharmacy services.
This register contains all websites that are authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) to sell medicines online, in Northern Ireland.
Recommendations from the independent Expert Advisory Group to the MHRA on the use of paclitaxel balloon catheters and stents to treat peripheral arterial disease.
Guidance and change control form to request a change to an Advisory Committee on Borderline Substances (ACBS) application form and/or guidance.
Advice for manufacturers of DMHTs that qualify as software as a medical device (SaMD) on understanding new post marketing surveillance rules and examples of how they apply.
Advice for manufacturers, members of the public and professional users of software or apps being used during the COVID-19 pandemic.
Information on medical facilities available in Timor-Leste.
A series of webinars providing guidance on the Windsor Framework agreement and the supply of medicines in Northern Ireland.
Supplementary information for international regulators on packaging changes and the export of UK medicines.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
How to move medicines safely by air, following good distribution practice (GDP).
Instructions for integrating with the new production MORE platform API.
Requirements and recommendations for sponsors and those conducting trials.
Guidance for Marketing Authorisation (MA) applicants on providing consent to share operational information during the MA application process.
Guidance to help medicine manufacturers meet safe limits on levels of nitrosamine impurities in medicines.
A summary of actions related to problems with T34 syringe drivers
UKHSA offers a unique opportunity to harness world-class intellectual, scientific, and operational expertise for public health solutions.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).